Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.

Benner MF, Jansen PM, Vermeer MH, Willemze R.

Blood. 2012 Feb 16;119(7):1643-9. doi: 10.1182/blood-2011-08-376319. Epub 2011 Dec 12.

PMID:
22160616
[PubMed - indexed for MEDLINE]
Free Article
2.

Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.

Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.

J Clin Oncol. 2010 Nov 1;28(31):4730-9. doi: 10.1200/JCO.2009.27.7665. Epub 2010 Sep 20.

PMID:
20855822
[PubMed - indexed for MEDLINE]
3.

Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.

Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.

Br J Dermatol. 2006 Oct;155(4):756-62.

PMID:
16965425
[PubMed - indexed for MEDLINE]
4.

Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.

Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R.

Blood. 1998 Aug 15;92(4):1150-9.

PMID:
9694702
[PubMed - indexed for MEDLINE]
Free Article
5.

Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.

Vergier B, de Muret A, Beylot-Barry M, Vaillant L, Ekouevi D, Chene G, Carlotti A, Franck N, Dechelotte P, Souteyrand P, Courville P, Joly P, Delaunay M, Bagot M, Grange F, Fraitag S, Bosq J, Petrella T, Durlach A, De Mascarel A, Merlio JP, Wechsler J.

Blood. 2000 Apr 1;95(7):2212-8. Review.

PMID:
10733487
[PubMed - indexed for MEDLINE]
Free Article
6.

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.

Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.

Arch Dermatol. 2003 Jul;139(7):857-66.

PMID:
12873880
[PubMed - indexed for MEDLINE]
7.

Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.

Kim YH, Bishop K, Varghese A, Hoppe RT.

Arch Dermatol. 1995 Sep;131(9):1003-8.

PMID:
7661601
[PubMed - indexed for MEDLINE]
8.

Prognostic factor analysis in mycosis fungoides/Sézary syndrome.

Diamandidou E, Colome M, Fayad L, Duvic M, Kurzrock R.

J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):914-24.

PMID:
10365922
[PubMed - indexed for MEDLINE]
9.

Prognostic factors in 105 Japanese cases of mycosis fungoides and Sézary syndrome: clusterin expression as a novel prognostic factor.

Tobisawa S, Honma M, Ishida-Yamamoto A, Saijo Y, Iizuka H.

J Dermatol Sci. 2013 Sep;71(3):160-6. doi: 10.1016/j.jdermsci.2013.04.020. Epub 2013 May 2.

PMID:
23702390
[PubMed - indexed for MEDLINE]
10.

Prognosis of 100 Japanese patients with mycosis fungoides and Sézary syndrome.

Suzuki SY, Ito K, Ito M, Kawai K.

J Dermatol Sci. 2010 Jan;57(1):37-43. doi: 10.1016/j.jdermsci.2009.10.010.

PMID:
19931424
[PubMed - indexed for MEDLINE]
11.

Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma.

Cerroni L, Rieger E, Hödl S, Kerl H.

Am J Surg Pathol. 1992 Jun;16(6):543-52.

PMID:
1599034
[PubMed - indexed for MEDLINE]
12.

A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.

Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, Mitchell TJ, Cox M, Ferreira S, Liu P, Robson A, Calonje E, Stefanato CM, Wilkins B, Scarisbrick J, Wain EM, Child F, Morris S, Duvic M, Whittaker SJ.

Eur J Cancer. 2013 Sep;49(13):2859-68. doi: 10.1016/j.ejca.2013.04.018. Epub 2013 Jun 1.

PMID:
23735705
[PubMed - indexed for MEDLINE]
13.

Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.

Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J.

Arch Dermatol. 2008 Jun;144(6):738-46. doi: 10.1001/archderm.144.6.738.

PMID:
18559762
[PubMed - indexed for MEDLINE]
14.

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.

Sausville EA, Eddy JL, Makuch RW, Fischmann AB, Schechter GP, Matthews M, Glatstein E, Ihde DC, Kaye F, Veach SR, et al.

Ann Intern Med. 1988 Sep 1;109(5):372-82.

PMID:
3408055
[PubMed - indexed for MEDLINE]
15.

Transformed mycosis fungoides: clinicopathological features and outcome.

Barberio E, Thomas L, Skowron F, Balme B, Dalle S.

Br J Dermatol. 2007 Aug;157(2):284-9. Epub 2007 Jun 15.

PMID:
17573879
[PubMed - indexed for MEDLINE]
16.

Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas.

Grange F, Hedelin G, Joly P, Beylot-Barry M, D'Incan M, Delaunay M, Vaillant L, Avril MF, Bosq J, Wechsler J, Dalac S, Grosieux C, Franck N, Esteve E, Michel C, Bodemer C, Vergier B, Laroche L, Bagot M.

Blood. 1999 Jun 1;93(11):3637-42.

PMID:
10339469
[PubMed - indexed for MEDLINE]
Free Article
17.

Recognizing large-cell transformation of mycosis fungoides.

Herrmann JL, Hughey LC.

J Am Acad Dermatol. 2012 Oct;67(4):665-72. doi: 10.1016/j.jaad.2011.12.011. Epub 2012 Jan 20.

PMID:
22261416
[PubMed - indexed for MEDLINE]
18.

Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients.

van Doorn R, Scheffer E, Willemze R.

Arch Dermatol. 2002 Feb;138(2):191-8.

PMID:
11843638
[PubMed - indexed for MEDLINE]
19.

Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients.

van Doorn R, Van Haselen CW, van Voorst Vader PC, Geerts ML, Heule F, de Rie M, Steijlen PM, Dekker SK, van Vloten WA, Willemze R.

Arch Dermatol. 2000 Apr;136(4):504-10.

PMID:
10768649
[PubMed - indexed for MEDLINE]
20.

Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.

Klemke CD, Mansmann U, Poenitz N, Dippel E, Goerdt S.

Br J Dermatol. 2005 Jul;153(1):118-24.

PMID:
16029336
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk